4//SEC Filing
Sawaf Aziz 4
Accession 0001415889-24-010326
CIK 0001583107other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 6:15 PM ET
Size
5.0 KB
Accession
0001415889-24-010326
Insider Transaction Report
Form 4
Sawaf Aziz
SVP & CHIEF FINANCIAL OFFICER
Transactions
- Award
Ordinary Shares
2024-04-02+100,000→ 338,636 total
Footnotes (1)
- [F1]On April 2, 2024, the reporting person was granted 100,000 RSUs. 37,500 RSUs are subject to service-based vesting conditions and the remaining 62,500 RSUs vest based on the achievement of share price appreciation targets as well as continued employment.
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0001961289
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 6:15 PM ET
- Size
- 5.0 KB